top of page

PLATFORM AND PRODUCTS

We are developing a broad portfolio of drug candidates that have the potential to meaningfully improve the lives of patients by directly addressing the causes and risk factors of neurological diseases. Each of our theraapeutic programs strictly follows the principles of our R&D strategy: selecting targets that are linked to the disease based on preclinical study, engineering our molecules to cross the blood-brain barrier, and guiding clinical development through the target selections and discovery and use of biomarkers.

BRAINCureâ„¢

BrainCureâ„¢ platform technology leverages unique AI/ML algorithms and relevant multiomics data and system biology approach to identify precision biomarkers and target molecules and de-risk accelerated drug discovery, repurposing and biomarker-based patient stratification.

GeneCureâ„¢

GeneCureâ„¢ is our flagship gene therapy platform that targets neurological diseases with precision and effectiveness.  We are developing gene editing technology in order to modifies diseased brain cells into vigorous cells.

ASOCureâ„¢

Learn More

ASOCureâ„¢ is a cutting-edge solution that addresses complex neurological conditions, providing hope for patients and families. Antisense Oligonucleotide (ASOCureâ„¢) is a Brainome proprietary platform exploited to target genetic neurological disease beyond conventional therapies.

Discover More

RNACureâ„¢

RNACureâ„¢ platform leverages mRNA carrying genetic information to restore brain cell function, whereas siRNA that interfere with gene expression by causing the degradation of specific mRNA targets, leading to silencing of the gene, offering promising outcomes for patients suffering from neurological disorders.

Explore

Our Prodcuts

siRNA Bio Pest Control 

siRNA Bio Pest Control 

Feed the world without polluting it.

selective Bio-pesticides for pathogen-resistant crops and enhanced agricultural products

The dairy and beef industries play a vital role in feeding billions of people every year. Our aim is to help dairy farmers and cattle ranchers around the world provide for our growing population while reducing their greenhouse gas emissions. We believe that a vaccine is the best way to achieve this goal, regardless of the farming system.

Balancing vast potential and unmet medical needTurn’s proprietary ERA™ Platform enables us to develop tailored therapies for an array of age-associated diseases that affect hundreds of millions of people. In many cases, medicine has found ways to treat the symptoms of these degenerative conditions – such as using analgesics to alleviate osteoarthritis pain or corrective lenses or surgery to improve vision. But medicine still has not found a way to cure the underlying diseases.Turn’s development pipeline is immediately focused on areas that promise the greatest benefit to patients whose medical need is clearly unmet by current science.

Learn More

Vaccinate every cow.

Feed the world without polluting it.

The dairy and beef industries play a vital role in feeding billions of people every year. Our aim is to help dairy farmers and cattle ranchers around the world provide for our growing population while reducing their greenhouse gas emissions. We believe that a vaccine is the best way to achieve this goal, regardless of the farming system.

Balancing vast potential and unmet medical needTurn’s proprietary ERA™ Platform enables us to develop tailored therapies for an array of age-associated diseases that affect hundreds of millions of people. In many cases, medicine has found ways to treat the symptoms of these degenerative conditions – such as using analgesics to alleviate osteoarthritis pain or corrective lenses or surgery to improve vision. But medicine still has not found a way to cure the underlying diseases.Turn’s development pipeline is immediately focused on areas that promise the greatest benefit to patients whose medical need is clearly unmet by current science:

Learn More

This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors.

RNA Vaccine LiveStock

Our goal is to reduce methane emissions from livestock through vaccination of cattle and buffalo. We're developing a vaccine using our ARNA Vac™ Platform that targets methane-producing microorganisms in their digestive systems, which will help combat climate change while maintaining dairy and beef production. This approach can be effective regardless of farming methods. By reducing greenhouse gas emissions from livestock, we aim to support dairy farmers and cattle ranchers in sustainably feeding the growing global population.

Learn More

Section Title

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

Contact Us

Screenshot 2025-05-20 at 12.40_edited.jpg

Quick Links​

 

About

Science

Products

Team

News

Investors

Careers

​

Our Pipeline

​

Overview

RNA Vac™-001

​ARNA™ -MS001

​ARNA™ -DEL001

​

Our Products

​

Overview

RNA Vac™-001

​ARNA™ -MS001

​ARNA™ -DEL001

​

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • TikTok

1000 Escalon Ave.,

Suite-204

Sunnyvale,  CA 94045

+1-(301)-648-3058

Subscribe to Our Newsletter

Contact Us

AgriRNA goal is to utilize next generation RNA technology for the impovement of eco-friendly animal and plant products.

©2025 – AgriRNA Biosciences. All Rights Reserved.

bottom of page